Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person10
Entera Bio Ltd.
Company
Zura Bio Ltd
Company
Entec Si Ltd
Company · 03170987
DDC Enterprise Ltd
Company
Biohaven Ltd.
Company
HONGCE ENTERPRISE Ltd
Company
Opera Ltd
Company
Enroly Ltd
Company · 10880551
BingEx Ltd
Company
ALLWYN ENTERTAINMENT LTD
Company · 13157556
Primary record18
Entera Bio Ltd. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 6, 2026, Entera Bio Ltd., a company organized under the laws of the State of Israel (“we,” “us,” “our” or the “Company”), issued a press release announ
Entera Bio Ltd. filed SCHEDULE 13G
(the "SEC") on October 14, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting P
Entera Bio Ltd. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Appointment of Dr. Juan Camilo Arjona Ferreira as Director On Oc
Eloxx Pharmaceuticals, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 19, 2026, the Board of Directors (the “Board”) of E
Entera Bio Ltd. filed DEF 14A
SEC form DEF 14A filed by Entera Bio Ltd. (CIK 1638097) on 2026-10-14.
Entera Bio Ltd. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Appointment of Laura Hamill as Director On October 6, 2026, the
Entera Bio Ltd. filed 8-K
Item 7.01 Regulation FD Disclosure. On August 18, 2026, Entera Bio Ltd., a company organized under the laws of the State of Israel ( we, us, our or the Company ), issued a press release announcing the appointment of Dr.
Nano Dimension Ltd. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 16, 2026, the Board of Directors (the “Board”) of Na
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 7, 2026, Entera Bio Ltd., a company organized under the laws of the State of Israel ( we, us, our or the Company ), issued a press release announcing its
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.
Entera Bio Ltd. filed 4
SEC form 4 filed by Entera Bio Ltd. (CIK 1638097) on 2026-08-07.